A new document from SCAI offers guidance on appropriate treatment of femoral-popliteal disease, defining "appropriate care," "care that may be appropriate" and "care that is rarely appropriate." "In the current era, our focus should be less on when we can apply endovascular therapy to when we should apply such therapy," said SCAI fellow Dr. Douglas E. Drachman, senior author of the document, which is the second in a series of SCAI PAD guidelines. "As a result, the [appropriate use criteria] document places particular emphasis on patient-driven factors, such as severity of clinical symptoms."

Related Summaries